FOLH1 and renal cell carcinoma: For example, Siva et al. [83] investigated the differential role of 18F-fluorodeoxyglucose (FDG) and PSMA-PET/CT scanning in patients with oligometastatic RCC, in particular the utility of PSMA PET/CT for assessment of diagnosis and therapeutic response.